MaxiVAX Company
MaxiVAX is a Swiss clinical-stage biotechnology company.
Technology:
Dendritic Cells
Industry:
Dendritic Cells
Headquarters:
Geneva, Geneve, Switzerland
Founded Date:
2005-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Total Funding:
8072217
Estimated Revenue:
$1M to $10M
Last Funding Date:
2019-11-27
Last Funding Type:
Series B
Register and Claim Ownership